GSA Capital Partners’s Kindred Biosciences, Inc. KIN Stock Holding History

GSA Capital Partners’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-52,257	Closed	-$479K	–	1921
2021 Q2	$479K	Buy	+52,257	New	+$304K	0.05%	656
2020 Q4	–	Sell	-43,260	Closed	-$186K	–	1752
2020 Q3	$186K	Buy	+43,260	New	+$181K	0.03%	1027

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

GSA Capital Partners's KIN Position: Q3 2021 in Review

GSA Capital Partners sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 52,257 shares — an estimated $479K sold.

GSA Capital Partners first reported a position in KIN in Q3 2020 and held it in 2 quarters. The position peaked at $479K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

GSA Capital Partners reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
GSA Capital Partners sold 52,257 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $479K.
GSA Capital Partners first reported a position in Kindred Biosciences, Inc. in Q3 2020 and held it in 2 quarters.
GSA Capital Partners's Kindred Biosciences, Inc. position peaked at $479K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.